Singularity War: Why Future Battles Will Be Fought by AI-Driven Weapons and AI Strategists

An apocalyptic vision of a million autonomous drones battling a million autonomous drones in the sky may sound like science ...

Allied Gold Announces Preliminary Third Quarter 2025 Operating Results

Allied will release its third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025. The Company will then host a conference call and webcast to review the results on ...

ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virol…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data ...

Rubicon Research IPO listing tomorrow: Here’s what GMP, subscription status hint ahead of debut

Rubicon Research IPO listing is on October 16, following a successful subscription period. The grey market signals a ...